• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺腺癌中双能CT碘图最佳采集延迟的评估:CT灌注Patlak模型的一种潜在替代方法

Evaluation of optimal acquisition delays of DECT iodine maps in pancreatic adenocarcinoma: A potential alternative to the Patlak model of CT perfusion.

作者信息

Skornitzke Stephan, Mayer Philipp, Kauczor Hans-Ulrich, Stiller Wolfram

机构信息

Diagnostic and Interventional Radiology (DIR), Heidelberg University Hospital, Heidelberg, Germany.

出版信息

Heliyon. 2023 Mar 22;9(4):e14726. doi: 10.1016/j.heliyon.2023.e14726. eCollection 2023 Apr.

DOI:10.1016/j.heliyon.2023.e14726
PMID:37064458
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10102198/
Abstract

INTRODUCTION

By using bolus tracking with an appropriate acquisition delay dual-energy computed tomography (DECT) iodine maps might serve as a replacement of CT perfusion maps at reduced radiation exposure. This study aimed to evaluate the optimal acquisition delays of DECT for the replacement of parameter maps calculated with the Patlak model in pancreatic adenocarcinoma by corresponding iodine maps.

MATERIALS AND METHODS

Dual-source dynamic DECT acquisitions at 80 kV/Sn140 kV of 14 patients with pancreatic carcinoma were used to calculate CT perfusion maps of blood volume and permeability with the Patlak model. DECT iodine maps were generated from individual DECT acquisitions, matching acquisition times relative to prior bolus-triggered three-phase CT acquisitions for investigating different acquisition delays. Correlation between perfusion parameters and iodine concentrations was determined for acquisition delays between -6 s and 33 s.

RESULTS

Correlation between iodine concentrations and perfusion parameters ranged from -0.05 to 0.63 for blood volume and from -0.05 to 0.71 for permeability, depending on potential trigger delay. The correlation was significant for potential acquisition delays above 1.5 s for blood volume and above 9.0 s for permeability (both p < 0.05). Maximum correlation occurred at an acquisition delay of 15.0 s for blood volume (r = 0.63) and at 25.5 s for permeability (r = 0.71), with significantly lower iodine concentrations in carcinoma (15.0 s: 1.3 ± 0.5 mg/ml; 22.5 s: 1.4 ± 0.7 mg/ml) than in non-neoplastic pancreatic parenchyma (15.0 s: 2.3 ± 0.8 mg/ml; 22.5 s: 2.4 ± 0.6 mg/ml; p < 0.05).

DISCUSSION

In the future, well-timed DECT iodine maps acquired with bolus tracking could provide an alternative to permeability and blood volume maps calculated with the Patlak model.

摘要

引言

通过使用团注追踪并设置合适的采集延迟,双能计算机断层扫描(DECT)碘图或许可以在降低辐射剂量的情况下替代CT灌注图。本研究旨在评估DECT的最佳采集延迟,以便用相应的碘图替代胰腺腺癌中用Patlak模型计算的参数图。

材料与方法

对14例胰腺癌患者进行80 kV/Sn140 kV的双源动态DECT采集,以用Patlak模型计算血容量和通透性的CT灌注图。从个体DECT采集中生成DECT碘图,使其采集时间与先前团注触发的三相CT采集时间相匹配,以研究不同的采集延迟。确定了-6秒至33秒采集延迟下灌注参数与碘浓度之间的相关性。

结果

根据潜在触发延迟,碘浓度与灌注参数之间的相关性,血容量为-0.05至0.63,通透性为-0.05至0.71。血容量在潜在采集延迟高于1.5秒时相关性显著,通透性在潜在采集延迟高于9.0秒时相关性显著(均p<0.05)。血容量在采集延迟15.0秒时相关性最大(r=0.63),通透性在采集延迟25.5秒时相关性最大(r=0.71),癌组织中的碘浓度(15.0秒:1.3±0.5mg/ml;22.5秒:1.4±0.7mg/ml)显著低于非肿瘤性胰腺实质(15.0秒:2.3±0.8mg/ml;22.5秒:2.4±0.6mg/ml;p<0.05)。

讨论

未来,通过团注追踪适时获取的DECT碘图可以替代用Patlak模型计算的通透性和血容量图。

相似文献

1
Evaluation of optimal acquisition delays of DECT iodine maps in pancreatic adenocarcinoma: A potential alternative to the Patlak model of CT perfusion.胰腺腺癌中双能CT碘图最佳采集延迟的评估:CT灌注Patlak模型的一种潜在替代方法
Heliyon. 2023 Mar 22;9(4):e14726. doi: 10.1016/j.heliyon.2023.e14726. eCollection 2023 Apr.
2
Dual-energy CT iodine maps as an alternative quantitative imaging biomarker to abdominal CT perfusion: determination of appropriate trigger delays for acquisition using bolus tracking.双能CT碘图作为腹部CT灌注的一种替代定量成像生物标志物:使用团注追踪确定采集的合适触发延迟
Br J Radiol. 2018 May;91(1085):20170351. doi: 10.1259/bjr.20170351. Epub 2018 Mar 7.
3
Correlation of quantitative dual-energy computed tomography iodine maps and abdominal computed tomography perfusion measurements: are single-acquisition dual-energy computed tomography iodine maps more than a reduced-dose surrogate of conventional computed tomography perfusion?定量双能 CT 碘图与腹部 CT 灌注测量的相关性:单期双能 CT 碘图是否优于常规 CT 灌注的低剂量替代方法?
Invest Radiol. 2015 Oct;50(10):703-8. doi: 10.1097/RLI.0000000000000176.
4
Measuring Dynamic CT Perfusion Based on Time-Resolved Quantitative DECT Iodine Maps: Comparison to Conventional Perfusion at 80 kVp for Pancreatic Carcinoma.基于时分辨量双能 CT 碘图的动态 CT 灌注测量:与 80 kVp 常规灌注在胰腺癌中的比较。
Invest Radiol. 2019 Nov;54(11):689-696. doi: 10.1097/RLI.0000000000000591.
5
Iodine Parameters in Triple-Bolus Dual-Energy CT Correlate With Perfusion CT Biomarkers of Angiogenesis in Renal Cell Carcinoma.三碘泡嘧啶参数与双能 CT 灌注 CT 生物标志物在肾细胞癌中的相关性。
AJR Am J Roentgenol. 2020 Apr;214(4):808-816. doi: 10.2214/AJR.19.21969. Epub 2020 Feb 18.
6
Correlation analysis of dual-energy CT iodine maps with quantitative pulmonary perfusion MRI.双能CT碘图与定量肺灌注MRI的相关性分析
World J Radiol. 2013 May 28;5(5):202-7. doi: 10.4329/wjr.v5.i5.202.
7
Virtual monoenergetic reconstructions of dynamic DECT acquisitions for calculation of perfusion maps of blood flow: Quantitative comparison to conventional, dynamic 80 kV CT perfusion.动态双能 CT 容积数据的虚拟单能量重建在血流灌注图计算中的应用:与常规 80kV 动态 CT 灌注的定量比较。
Eur J Radiol. 2020 Oct;131:109262. doi: 10.1016/j.ejrad.2020.109262. Epub 2020 Aug 31.
8
Dual-energy perfusion-CT of pancreatic adenocarcinoma.胰腺腺癌的双能量灌注 CT。
Eur J Radiol. 2013 Feb;82(2):208-14. doi: 10.1016/j.ejrad.2012.09.012. Epub 2012 Oct 11.
9
Can quantitative iodine parameters on DECT replace perfusion CT parameters in colorectal cancers?DECT 上的定量碘参数能否替代结直肠癌中的灌注 CT 参数?
Eur Radiol. 2018 Nov;28(11):4775-4782. doi: 10.1007/s00330-018-5502-3. Epub 2018 May 22.
10
Can dual-energy CT replace perfusion CT for the functional evaluation of advanced hepatocellular carcinoma?双能 CT 能否替代灌注 CT 对晚期肝细胞癌进行功能评估?
Eur Radiol. 2018 May;28(5):1977-1985. doi: 10.1007/s00330-017-5151-y. Epub 2017 Nov 22.

引用本文的文献

1
Contrast-enhanced photon-counting detector CT for discriminating local recurrence from postoperative changes after resection of pancreatic ductal adenocarcinoma.对比增强光子计数探测器CT用于鉴别胰腺导管腺癌切除术后局部复发与术后改变。
Eur Radiol Exp. 2025 Feb 22;9(1):26. doi: 10.1186/s41747-025-00567-0.

本文引用的文献

1
Objective and subjective comparison of virtual monoenergetic vs. polychromatic images in patients with pancreatic ductal adenocarcinoma.胰腺导管腺癌患者虚拟单能量与多光谱图像的客观和主观比较。
Eur Radiol. 2019 Jul;29(7):3617-3625. doi: 10.1007/s00330-019-06116-9. Epub 2019 Mar 19.
2
Iodine quantification to distinguish hepatic neuroendocrine tumor metastasis from hepatocellular carcinoma at dual-source dual-energy liver CT.双源双能 CT 碘定量鉴别肝脏神经内分泌肿瘤转移与肝细胞癌。
Eur J Radiol. 2018 Aug;105:20-24. doi: 10.1016/j.ejrad.2018.05.019. Epub 2018 May 19.
3
Can quantitative iodine parameters on DECT replace perfusion CT parameters in colorectal cancers?DECT 上的定量碘参数能否替代结直肠癌中的灌注 CT 参数?
Eur Radiol. 2018 Nov;28(11):4775-4782. doi: 10.1007/s00330-018-5502-3. Epub 2018 May 22.
4
Assessment of iodine uptake by pancreatic cancer following chemotherapy using dual-energy CT.用双能 CT 评估化疗后胰腺癌的碘摄取。
Abdom Radiol (NY). 2018 Feb;43(2):445-456. doi: 10.1007/s00261-017-1338-6.
5
Dual-energy CT iodine maps as an alternative quantitative imaging biomarker to abdominal CT perfusion: determination of appropriate trigger delays for acquisition using bolus tracking.双能CT碘图作为腹部CT灌注的一种替代定量成像生物标志物:使用团注追踪确定采集的合适触发延迟
Br J Radiol. 2018 May;91(1085):20170351. doi: 10.1259/bjr.20170351. Epub 2018 Mar 7.
6
Can dual-energy CT replace perfusion CT for the functional evaluation of advanced hepatocellular carcinoma?双能 CT 能否替代灌注 CT 对晚期肝细胞癌进行功能评估?
Eur Radiol. 2018 May;28(5):1977-1985. doi: 10.1007/s00330-017-5151-y. Epub 2017 Nov 22.
7
Multiple Myeloma and Dual-Energy CT: Diagnostic Accuracy of Virtual Noncalcium Technique for Detection of Bone Marrow Infiltration of the Spine and Pelvis.多发性骨髓瘤与双能量 CT:虚拟非钙技术检测脊柱和骨盆骨髓浸润的诊断准确性。
Radiology. 2018 Jan;286(1):205-213. doi: 10.1148/radiol.2017170281. Epub 2017 Aug 11.
8
Dual-Energy Perfusion-CT in Recurrent Pancreatic Cancer - Preliminary Results.双能量灌注CT在复发性胰腺癌中的应用——初步结果
Rofo. 2016 Jun;188(6):559-65. doi: 10.1055/s-0042-105765. Epub 2016 May 25.
9
Correlation between Dual-Energy and Perfusion CT in Patients with Hepatocellular Carcinoma.肝细胞癌患者双能量 CT 与灌注 CT 的相关性。
Radiology. 2016 Jul;280(1):78-87. doi: 10.1148/radiol.2015151560. Epub 2016 Jan 29.
10
Iodine concentration as a perfusion surrogate marker in oncology: Further elucidation of the underlying mechanisms using Volume Perfusion CT with 80 kVp.碘浓度作为肿瘤学中的灌注替代标志物:使用80 kVp的容积灌注CT进一步阐明潜在机制。
Eur Radiol. 2016 Sep;26(9):2929-36. doi: 10.1007/s00330-015-4154-9. Epub 2015 Dec 17.